UBS raises Apellis Pharmaceuticals shares target on strong outlook By Investing.com
UBS raises Apellis Pharmaceuticals shares target on strong outlook…
34,978€
0,09%
Echtzeit-Aktienkurs Apellis Pharmaceuticals
Bid:
Ask:
Nachrichten zur Apellis Pharmaceuticals Aktie
Apellis Pharmaceuticals, Inc. (APLS) Q4 and Full Year 2023 Earnings Call Transcript
…
Apellis Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation
…
Apellis Pharmaceuticals Q4 2023 Earnings Preview
…